| 1 |
Hirota S, Isozaki K, MoriyamaY, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science, 1998, 279(5350):577-580.
|
| 2 |
Heinrich MC,Corless CL,Duensing A,et al.PDGFRA activating mutations in gastrointestinal stromal tumors.Science,2003,299(5607):708-710.
|
| 3 |
Ou WB,Zhu MJ,Demetri GD,et al.Protein kinase C-theta regulates KIT expression and proliferation in gastrointestinal stromal tumors.Oncogene,2008 Jun 2.
|
| 4 |
Raut CP,DeMatteo RP.Prognostic factors for primary GIST:prime time for personalized therapy?Ann Surg Oncol,2008,15(1):4-6.
|
| 5 |
Demetri GD,Benjamin RS,Blanke CD,et al.NCCN Task Force report:management of patients with gastrointestinal stromal tumor(GIST)--update of the NCCN clinical practice guidelines.J Natl Compr Canc Netw,2007,5(Suppl 2):S1-29.
|
| 6 |
Keun Park C, Lee EJ, Kim M, et al. Prognostic stratification of high-risk gastrointestinal stromal tumors in the era of targeted therapy. Ann Surg, 2008,247(6):1011-1018.
|
| 7 |
Dematteo RP, Gold JS, Saran L, et al. Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor(GIST).Cancer,2008,112(3):608-615.
|
| 8 |
Braconi C,Bracci R,Bearzi I,et al.Insulin-like growth factor (IGF)1 and 2 help to predict disease outcome in GIST patients.Ann Oncol,2008,19(7):1293-1298.
|
| 9 |
DeMatteo RP,Lewis JJ,Leung D,et al.Two hundred gastrointestinal stromal tumors:recurrence patterns and prognostic factors for survival.Ann Surg,2000,231(1):51-58.
|
| 10 |
Novitsky YW, Kercher KW, Sing RF, et al. Long-term outcomes of laparoscopic resection of gastric gastrointestinal stromal tumors. Ann Surg, 2006,243(6):738-745.
|
| 11 |
Davies AR,Ahmed W,Purkiss SF.Port site metastasis following diagnostic laparoscopy for a malignant Gastro-intestinal stromal tumour.World J Surg Oncol,2008,6:55.
|
| 12 |
Van den Abbeele AD,Badawi RD.Use of positron emission tomography in oncology and its potential role to assess response to imatinib mesylate therapy in gastrointestinal stromal tumors(GISTs).Eur J Cancer,2002,38(Suppl 5):S60-65.
|
| 13 |
Souya N, Tsuyoshi, Kazuaki, et al. Surgery including liver resection for metastatic gastrointestinal stromal tumors or gastrointestinal leiomyosarcomas.Jpn J Clin Oncol,2005,35(6):338-341.
|
| 14 |
Blanke CD,Demetri GD,von Mehren M,et al.Long-term results from a randomized phase II trial of standard-versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT.J Clin Oncol,2008,26(4):620-625.
|
| 15 |
DeMatteo RP,Maki RG,Singer S,et al.Results of tyrosine kinase inhibitor therapy followed by surgical resection for metastatic gastrointestinal stromal tumor.Ann Surg,2007,245(3):347-352.
|
| 16 |
Raut CP,Posner M,Desai J,et al.Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors.J Clin Oncol,2006,24(15):2325-2331.
|
| 17 |
Demetri GD,Van Oosterom AT,Garrett CR,et al.Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib:a randomised controlled trial.Lancet,2006,368(9544):1329-1338.
|